Cartilago

Cartilago harnesses regenerative medicine to develop disease-modifying, chondroprotective technologies for combatting osteoarthritis and related pathologies. Cartilago directly target underlying disease pathology to offer not just symptomatic relief, but also to inhibit the typical natural progression of the disease. The technologies are being adapted to address additional indications, including for anti-aging solutions, wound care and anti-metastatic therapies in cancer.